Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis

PURPOSE: Immune checkpoint inhibitors have developed rapidly and have demonstrated antitumor activity in various cancers. To evaluate the safety and efficacy of atezolizumab in treating cancers, we conducted this meta-analysis. METHODS: Embase, PubMed, MEDLINE, the Central Register of Controlled Tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tie, Yan, Yang, Hui, Zhao, Rui, Zheng, Heng, Yang, Daoke, Zhao, Jingyi, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366347/
https://www.ncbi.nlm.nih.gov/pubmed/30787594
http://dx.doi.org/10.2147/DDDT.S188893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366347/
https://www.ncbi.nlm.nih.gov/pubmed/30787594
http://dx.doi.org/10.2147/DDDT.S188893

Ejemplares similares